Skip To Main Content
Yingfei Xi on Muck Rack

Yingfei Xi

As seen in: Frontiers, Nutrition & Metabolism
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Yingfei

Contact Yingfei, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Frontiers | Correction: Geniposide plus chlorogenic acid reverses non-alcoholic steatohepatitis via regulation of gut microbiota and bile acid signaling in a mouse model in vivo

|
By Hongshan Li, Yingfei Xi, Xin Xin, Qin Feng, Yiyang Hu
| Frontiers
CORRECTION article Volume 16 - 2025 | https://doi.org/10.3389/fphar.2025.1657343 In the Funding statement, an incorrect number was provided for National Natural Science Foundation of China (#82174189 and #81873109). The correct number is National Natural Science Foundation of China (#82174186 and #81873109). The original article has been updated.
Open in Who Shared Issue with article?

Identification of tRNA-derived RNAs in adipose tissue from overweight type 2 diabetes mellitus patients and their potential biological functions

|
By Shitao Rao, Mai Shi, Zhaoxing Dong, Yingfei Xi
| Frontiers
1 Introduction Type 2 diabetes mellitus (T2DM) is a cause of human suffering, with its prevalence increasing annually, affecting over 400 million people worldwide. This condition can severely compromise patients’ quality of life, lead to significant premature deaths, and place a heavy economic burden on global health resources (1, 2). Overweight or obesity, another common metabolic disorder, is now a recognized risk factor for T2DM (2).
Open in Who Shared Issue with article?

Gypenosides regulate farnesoid X receptor-mediated bile acid and lipid metabolism in a mouse model of non-alcoholic steatohepatitis

|
By Xin Xin, Hongshan Li, Yingfei Xi, Huajie Tian
| Nutrition & Metabolism Verified
Abstract Background Gypenosides (Gyp) are the main ingredient of the Chinese medicine, Gynostemma pentaphyllum. They are widely used in Asia as a hepatoprotective agent. Here, we elucidated the mechanism of Gyp in non-alcoholic steatohepatitis (NASH) with a focus on farnesoid X receptor (FXR)-mediated bile acid and lipid metabolic pathways. Methods NASH was induced in mice by high-fat diet (HFD) feeding, while mice in the control group were given a normal diet.
Open in Who Shared Issue with article?
See all 3 articles